Fierce Healthcare

JANUARY 6, 2022

Forrester: Here are 4 key frontiers for healthcare innovation over the next decade. pminemyer. Thu, 01/06/2022 - 12:54.

141

141

pharmaphorum

JANUARY 4, 2022

The global R&D pipeline is dominated by potential treatments in oncology and this is also where the investment is flowing. This doesn’t look like changing moving into the future, the main challenge will be managing to use this money to create a proportionate number of approved treatments and ensuring an early diagnosis for patients in the area. In this article, Ben Hargreaves explores how advances in technology could address these challenges.

140

140

Outsourcing Pharma

JANUARY 3, 2022

An R&D leader from the explains its proactive approach to staying on top of supply chain challenges, including a new dedicated manufacturing line in China.

87

87

Pharma Times

JANUARY 5, 2022

The test is a technological first in determining the metastatic status of a cancer without using prior insight of the primary cancer presented.

66

66

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Fierce Healthcare

JANUARY 7, 2022

CMS issued over 300 warnings, but no fines, to hospitals falling short on price transparency last year. dmuoio. Fri, 01/07/2022 - 17:39.

Hospitals 138

Hospitals 138

pharmaphorum

JANUARY 5, 2022

A COVID-19 vaccine that could work against multiple variants of the coronavirus – developed by US biotech Gritstone bio – has generated encouraging immune response data in its first clinical trial. The new vaccine differs from the currently approved shots because it delivers antigens for both the spike protein and other proteins found in SARS-CoV-2.

Vaccines 126

Vaccines Immunization Communication 126

Turnkey Pharmacy Solutions

JANUARY 7, 2022

When I was young, I remember my dad saying time and time again, “knowledge is power.” He was always on a quest to learn and to know why or how things worked. It was then, as he felt, his duty to educate my sisters and me. He would end his tutorial with “And now you.

52

52

Fierce Healthcare

JANUARY 5, 2022

Magellan Healthcare, NeuroFlow team up on digital mental health program for members. agliadkovskaya. Wed, 01/05/2022 - 18:58.

137

137

pharmaphorum

JANUARY 7, 2022

AstraZeneca has clearly made the rare disease transthyretin amyloidosis (ATTR) a key component of its rare disease pipeline, licensing a second drug candidate in the space of a couple of months. In the latest deal, the pharma group is paying $30 million upfront with another $730 million in milestone’s for global rights to Neurimmune’s NI006, a drug in early-stage clinical for cardiomyopathy, a progressive and fatal complication affecting some patients with ATTR.

Labelling 116

Labelling Immunization 116

Outsourcing Pharma

JANUARY 3, 2022

A representative from IFF Pharma Solutions talks about significant challenges in drug development and improvements the industry can implement to overcome them.

68

68

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

The Physician Pharmacist

JANUARY 7, 2022

As a pharmacy student interested in a career in medicine, it's imperative that you have an appreciation for the medical school application cycle timeline! It's already hard balancing your pharmacy school obligations, so don't make it harder on yourself by skipping over this crucial timeline! If you know what's on the horizon, you can chart your journey and navigate your application to the promised land!

Medical Schools 52

Medical Schools 52

Fierce Healthcare

JANUARY 4, 2022

Hackers hit Broward Health network, potentially exposing data on 1.3M patients, staff. hlandi. Tue, 01/04/2022 - 17:14.

135

135

pharmaphorum

JANUARY 6, 2022

We spoke with Tanja Dowe, ahead of the annual J.P. Morgan Health Care Conference 2022, about radical innovation in healthcare, including the potential of digital solutions to diagnose disease earlier, using digital therapeutics or preventive digital solutions more efficiently, and making use of technologies that result in accelerated drug discovery and development.

Pharmaceutical Companies 116

Pharmaceutical Companies Pharmaceutical Companies Hospitals 116

Outsourcing Pharma

JANUARY 6, 2022

Clover Biopharmaceuticals, a clinical-stage biotech developing novel vaccines and biologic therapeutic candidates, has started construction on a new R&D Center in Zhangjiang Biotech and Pharmaceutical Industrial Base in Shanghai.

Vaccines 65

Vaccines 65

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Tutor

JANUARY 7, 2022

Durian - the King of fruits for health. Manisha Choudhary 1 , Rajesh Vagh 2 , MM Abid Ali Khan 3 , Raaz K. Maheshwari* 4. admin. Sat, 01/08/2022 - 11:09. Tags. Articles.

52

52

Fierce Healthcare

JANUARY 7, 2022

Justices appear likely to narrowly uphold CMS vaccine mandate on hold in half of US. rking. Fri, 01/07/2022 - 15:44.

Vaccines 134

Vaccines 134

pharmaphorum

JANUARY 7, 2022

It’s no secret that fertility treatment is expensive and has a low success rate, placing a big financial and emotional burden on would-be parents. Now, a Canadian startup aims to tackle that problem though the use of artificial intelligence. Toronto-based Future Fertility has developed an AI called Violet that it says can predict the viability of cryopreserved eggs used for in vitro fertilisation (IVF), making sure that those most likely to result in a successful procedure.

Insurance 115

Insurance 115

Outsourcing Pharma

JANUARY 4, 2022

A forward-looking report from company experts includes a breakdown of the top trends to watch for in pharmaceutical development and in healthcare overall.

64

64

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Roots Analysis

JANUARY 6, 2022

Myeloid cells represent a group of cells containing granulocytes, monocytes, macrophages, mast cells and dendritic cells, which play a key role in innate immunity. These cells are found in abundance in the tumor microenvironment and inflamed areas. The tumor recruits and modulates endogenous myeloid cells to tumor-associated macrophages, dendritic cells, myeloid-derived suppressor cells and neutrophils, to sustain an immunosuppressive environment.

Immunization 52

Immunization Vaccines 52

Fierce Healthcare

JANUARY 7, 2022

Healthcare smashed venture funding records in 2021 despite poor market performance. rtorrence. Fri, 01/07/2022 - 11:34.

133

133

pharmaphorum

JANUARY 5, 2022

The FDA thinks an antibody-drug conjugate (ADC) developed by AbbVie could set new standards in treatment for certain patients with lung cancer, awarding the drug breakthrough status. Teliso-V (telisotuzumab vedotin) is pitching to become the first targeted cancer treatment for people with non-small cell lung cancer (NSCLC) whose tumours overexpress c-Met.

FDA 111

FDA Chemotherapy 111

Outsourcing Pharma

JANUARY 3, 2022

A leader from the clinical trial technology company says that insights gained during the recent pandemic could be helpful in realizing future improvements.

59

59

Pharma Mirror

JANUARY 6, 2022

ADELAIDE, AUS – TrialWire(TM) is pleased to announce new B-cell lymphoma clinical studies are now available on the TrialWire Platform. More than 6 million people have used TrialWire over the past few years to find clinical trials that are right for them at clinics and specialist centers near them. The studies on TrialWire are available in Australia, New Zealand, and the U.S.

52

52

Fierce Healthcare

JANUARY 6, 2022

Study examines differences in coverage denials for traditional Medicare, MA. agliadkovskaya. Thu, 01/06/2022 - 17:00.

133

133

pharmaphorum

JANUARY 7, 2022

If the last couple of days is an indication, 2022 is already shaping up to be the year of big-ticket alliances between big pharma companies and specialists in artificial intelligence-driven discovery. Shortly after Amgen unveiled its $1.9 billion alliance with Generate Biomedicines aimed initially at five drug molecules, Sanofi has announced a big expansion of its longstanding partnership with Exscientia that covers no fewer than 15 programmes.

Immunization 110

Immunization 110

Outsourcing Pharma

JANUARY 6, 2022

This monthâs news on mergers and acquisitions, hires, and other developments includes notable firms like Altasciences, Protocol First, WuXi STA, and more.

52

52

Pharma Marketing Network

JANUARY 5, 2022

Tune in to this episode of the Pharma Marketing Podcast to hear from our guest, Chris Wasden, Head of Pharma Specialty Solutions & Corporate Strategy at Happify Health and Jennifer Ginest, Digital Marketing Manager of PMN , discuss the current role of Digital Therapeutics in Healthcare and were it is headed.

52

52

Fierce Healthcare

JANUARY 7, 2022

Here are the hospitals postponing elective surgeries amid the omicron surge. agliadkovskaya. Fri, 01/07/2022 - 15:49.

Hospitals 131

Hospitals 131

pharmaphorum

JANUARY 7, 2022

Kidney cancer is the 14 th most common cancer, with approximately 400,000 new cases worldwide every year. Renal cell carcinoma (RCC) is by far the most prevalent type of cancer originating from the kidney, making up nine out of ten kidney cancer diagnoses. As chief medical officer, head of global medical affairs, patient safety and patient affairs – putting patient interests first is central to my role and values.

Patient Care 105

Patient Care 105

Outsourcing Pharma

JANUARY 6, 2022

In a report outlining predictions for the coming year, the organization advises industry professionals to brace themselves for supply chain challenges.

52

52

Pharma Marketing Network

JANUARY 5, 2022

If your New Year’s Resolutions include finally cracking the code to deliver Next Best Actions for every HCP engagement, these experts have some advice. Embedding data-driven practices into your organization requires resilience, persistence, and organization-wide governance and commitment. With large global organizations, how do you move toward one shared vision when the business is scattered around the world?

52

52

Fierce Healthcare

JANUARY 4, 2022

Walmart Health exec Osborne leaves the retailer amid ongoing leadership changes. hlandi. Tue, 01/04/2022 - 13:17.

128

128

pharmaphorum

JANUARY 6, 2022

Roche’s idiopathic pulmonary fibrosis (IPF) therapy Esbriet is already being squeezed by its main rival in the market, and could come under renewed pressure if another competitor from PureTech Health gets approved. PureTech is developing a modified version of the active ingredient in Esbriet (pirfenidone) that has just been shown to be less likely to cause gastrointestinal side effects than Roche’s drug in a proof-of-concept trial.

FDA 105

FDA 105